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Abstract
Background: Benign neutropenia often presents in certain populations without any genotype nor phenotype.
Middle East countries are among the regions where endemic cases of chronic benign neutropenia are reported in
the general population with an incidence of approximately between 10-15%. Not many studies have been
performed to ascertain the cause or burden associated with this condition. The objective of the current study was
to identify the frequency and characterize the consequences of chronic benign neutropenia in the country of
Saudi Arabia.
Results: Benign neutropenia was found to be high in the Saudi Arabia general population (up to 20%), with an
average neutrophil count of 1.48 (range 0.99 – 1.95 × 109cells/L), with Saudis having a higher incidence of chronic
benign neutropenia compared to non-Saudis (p = <0.05). Complete blood count analyses showed significant
difference in the total white cell count of neutrophils (p < 0.0001), WBC (p < 0.0001), lymphocytes (p < 0.001),
monocytes (p < 0.001), eosinophils (p = 0.013) as well as the CD19 B cells (p = 0.008).
Conclusions: Our study is the first to carefully quantitate benign neutropenia in Saudi Arabia. We identified that
this condition is prevalent in the middle aged population (18 years to 55 years). These individuals not only had
lower neutrophil counts, but also reduced peripheral blood cells types, especially the B-lymphocyte population
(CD19 subset). As B-lymphocytes are involved in antibody production and antigen recognition, a decrease might
easily predispose the individuals to infectious agents. As such more mechanistic studies need to be undertaken to
understand the cause and potential long-term consequences of benign neutropenia.
Background
Neutropenia is commonly defined as a decrease in the
absolute number of neutrophils, which is the predomi-
nant cell type among the various fractions of the white
blood cells. Abnormal low levels of neutrophils (neutro-
penia) is an important risk factor for infection, and may
be classified as mild (1.0 to 1.5 x 109/L), moderate
(0.5 to 1.0 × 109/L), or severe (<0.2 × 109/L, 2 < 0.5 ×
109/L) [1]. If left untreated this could lead to different
forms of chronic disease conditions [2]. Neutropenia is
broadly classified into the severe chronic neutropenia
(SCN) and acquired or secondary neutropenia [3]. SCN
includes the heterogeneous group of congenital condi-
tions (bone-marrow failure syndromes, inborn errors of
metabolism, immunodeficiencies etc); as well as cyclical
and idiopathic neutropenia [3]. Acquired neutropenia
can be due to drug toxicity, radiotherapy, infection,
immune mediated diseases, haematological diseases and
collagen vascular disorders [3]. However, neutropenia is
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mostly associated with patients undergoing chemother-
apy or radiotherapy for malignancies such as leukaemia,
lymphoma and thymoma. Benign ethnic neutropenia is
another form of neutropenia and is prevalent in
approximately 25% to 50% of the African as well as
Middle Eastern population [1]. Individuals with benign
neutropenic condition usually present with consistent
low absolute neutrophil counts with no obvious
increased susceptibility to infection.
It has been observed that certain healthy people at rou-
tine checkups present with low neutrophil counts that is
not associated with any obvious disease burden [4,5].
This condition is known as benign neutropenia or in
some cases chronic benign neutropenia (CBN). Chronic
benign neutropenia in otherwise healthy subjects has
been observed in different groups, such as Africans [6],
African Caribbean people [7], Ethiopians, Yemenite Jews
[8,9] and certain Arab populations. Prevalence of isolated
endemic incidences of benign neutropenia has been
previously reported in the Middle Eastern countries
[8,10,11]. However, the specific risk of defined genetic
subgroups has largely remained unknown. A recent
report by Denic et al., (2010) [4] showed that the mean
neutrophil count in Arabs is lower than those found in
individuals who are from European origin [4]. The root
cause for the origin of this benign condition is still not
understood. Understanding the cause for chronic benign
neutropenia (CBN) will be crucial for the management
of this disease in the general population. A genetic cause,
an autosomal dominant mode for transmission of the
disease [4], has been postulated however this requires
extensive validation studies.
The incidence of CBN condition shows variation
between males and females with males being more prone
to this condition [5]. Recurrent infections, especially
chest infection, bacterial and viral infections are some
indicators for CBN [10]. Smoking has also been attribu-
ted as a major cause for the occurrence of CBN [12].
Association of CBN with any long-term disease is not
known. Patients with CBN do not present with unique
clinical features and do not appear to have any difference
in outcomes for common forms of infections such as the
respiratory infections, between individuals with and with-
out neutropenia from the same ethnic population. Some
of the patients with CBN were found to have normal
bone marrow morphology as well as other leukocyte
counts (lymphocytes, basophils, eosinophils, and mono-
cytes). In some instances CBN is associated with several
clinical manifestations ranging from mild infections to
severe disease conditions. In certain random cases
patients identified with severe congenital neutropenia
were associated with a premalignant condition with an
increased risk of clonal hematopoietic diseases such as
MDS and leukaemia [13].
Very few studies have been reported on the incidence
and the underlying pattern of this disease. Based on our
literature review there were no previous report on the pre-
valence of this disease in the kingdom of Saudi Arabia
which has a total population between 25 and 35 million.
Considering the previous reports, 10-15% prevalence in
the Middle East, this could results in a significant number
of subjects in the Kingdom to this benign condition. Thus,
in the present study, we tested 100 samples from subjects
who came for regular screening and were not treated for
any specific disease, at the King Abdulaziz University Hos-
pital in Jeddah, Kingdom of Saudi Arabia. The current
study evaluated the frequency of CBN in the normal popu-
lation samples and a total of 19 different parameters were
analyzed. To achieve our objectives, we used flow cytome-
try to measure cell population data (CPD) as well as cell
surface markers to more specifically categorize the periph-
eral blood lymphocytes on subjects with CBN compared
to subjects without CBN. To our knowledge the current
study is the first of its type to look into factors associated
with CBN in the Middle East population focused on the
general population in the Kingdom of Saudi Arabia.
Methods
Peripheral blood samples were obtained from patients
and healthy volunteers (males, 18 - 55 years; females,
18 - 50 years) into dipotassium EDTA-anticoagulant in
Vacutainer tubes (Becton Dickinson, Franklin Lakes, NJ,
USA) and stored at room temperature. Absolute blood
cell counts as well as peripheral blood lymphocyte counts
were determined using BD FACS Canto II flow cyt-
ometer (San Jose, California, USA) using fluorescent
labelled antibodies. In this pilot study 100 samples
obtained from normal healthy subjects were analzyed.
The subjects enrolled in the study are ethnic to Saudi
Arabia and included both Saudi (n = 69) and non-Saudi
(n = 31) population. The subjects were randomly selected
from those visiting the hospital for routine check-up.
There was no bias associated in selection of individuals
and the final study group comprised of 89 males and 11
females. The questionnaire collected included history of
smoking, acute and chronic infection at different sites,
active autoimmune disease, drug therapy, family history
and pregnancy if the subject is female, The following
parameters namely, history of (1) bacterial infection,
(2) viral infection, (3) rheumatic infection, (4) skin infec-
tion, (5) diarrhoea, (6) chest infection, (7) ear infection,
(8) history of medication, (9) herpes infection, (10) smok-
ing habits, (11) osteoarthritis, (12) pregnancy, (13) Sys-
temic lupus erythematosus (SLE), (14) rheumatoid
arthritis (RA), (15) current cancer therapy, (16) vitamin
deficiencies, and (17) radiation therapy were included in
the study to understand the underlying cause for the
cause for CBN.
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Cell population data (CPD) was collected for (1) WBCs,
(2) neutrophils, (3) lymphocytes, (4) monocytes, (5) eosi-
nophils and (6) basophils. Peripheral blood lymphocyte
subsets (CD3, CD3+CD8, CD3+CD4, CD16+CD56 and
CD19) were quantified to study the role of T-cells, lym-
phocytes, B-cells and their association with CBN.
Statistical analysis
All statistical analyses were performed using the Statisti-
cal Package for Social Sciences (SPSS) software version
20.0 (SPSS, Chicago, IL, USA). The risk factors for the
incidence of CBN were evaluated by Chi-square test for
categorical variables, and Mann-Whitney U test for
numerical variables. Correlation between neutrophil
counts with other parameters was evaluated by Pearson’s
correlation coefficient.
Ethical approval
The study was approved by the ethical committee at the
Centre of Excellence in Genomic Medicine Research
(CEGMR), King Abdulaziz University (HA-02-J-003),
following the ethical standards and guidelines of the
National Ethical Committee of Saudi Arabia. Written
informed consent was obtained from all individuals who
participated in the current study and all were all adults.
Results and discussion
The summary characteristics of 100 subjects with various
parameters (19 parameters) used for the current study
are provided in Table 1. Based on the current study on
the subjects (healthy adults) we did not find any signifi-
cant association between the prevalence of CBN with the
19 parameters on the decrease in the neutrophil count
except for the age and nationality. Saudi nationality was
found to be more susceptible to this disease condition
compared to the non-Saudi population. All patients diag-
nosed with CBN were found to have low white blood
cells differential count except for basophils. Total lym-
phocytes, eosinophils, and CD19 subset showed signifi-
cant differences in the subjects with CBN compared to
those who had normal neutrophil count (Table 2).
Peripheral blood lymphocyte subsets, CD3, CD3+CD8,
CD3+CD4, CD16+CD56 showed no correlation with
CBN except for CD19. CD3 (T-cells), CD3 + CD8 (lym-
phocytes), and CD3 + CD4 (T-cells) showed negative
correlation with neutrophils. B-lymphocyte antigen
(CD19) alone showed significant difference in the expres-
sion pattern (r = 0.395; p = <0.0001) in healthy subjects
when matched against patients with the benign disease
condition. The trend in neutrophils count in subjects
with CBN generally correlated with (1) WBC (r = 0.802);
(2) lymphocytes, (r = 0.301); (3) monocytes, (r = 0.297);
(4) eosinophils, (r = 0.221) and (5) basophils (r = 0.143)
(Table 3). Neutrophil counts in patients and CD counts
were found to be positively correlated with CD19 (r =
0.395) and CD16+CD56 (r = 0.00) and inversely corre-
lated with CD3 + CD4 (r = -0.110), CD3 (r = -0.279) and
CD3+CD8 (r = -0.229) (Table 4).
The incidence of CBN is more common in certain
endemic regions across the globe. The real prevalence of
this disease is still not fully established. The prevalence
of this disease is also on the rise in the Middle East
population due to several factors, consanguinity of mar-
riages perhaps being one of the reasons. The current
study has shown an increasing trend in the incidence of
this disease based on previous reports [11]. Our study
has shown a decreasing trend in the neutrophil count in
non-symptomatic populations which is associated with a
general decrease in the total blood cell count for WBCs,
leucocytes, monocoytes, eosinophils and the CD19 sub-
set (B-lymphocyte). This trend could lead to a more
chronic disease condition in the patients affected by this
condition. Efforts should be initiated to understand the
molecular cause for the decrease in the TBC count in
this target population.
Benign ethnic neutropenia has been previously
reported in American and British population of African
descent and has been associated with a regulatory
Table 1 Table describing the 19 parameters used to
ascertain the health status of subjects who enrolled for
the current study. Statistical analysis was carried out to
determine the significance of low neutrophil count and
its association with the 19 parameters described in the
table. A p value of < 0.05 is considered to be significant.
Y = yes; N = no, NA = not applicable
Number Parameters Y/N/NA p - value
1 Gender (Male Female) N p- value
2 Age V p = 0.306
3 Nationality (Saudi / non-Saudi) Y p = 0.001
4 History of bacterial infection NA p < 0.050
5 History of viral infection NA NA
6 History of rheumatic infection N NA
7 History of Skin infection N p = 0.403
8 History of diarrhoea N p = 0.618
9 History of chest infection N p = 0.508
10 History of ear infection N p = 0.122
11 History of medication N p = 0.403
12 History of smoking N p = 0.440
13 History of arthritis N p = 0.443
14 Pregnancy NA p = 0.50S
15 Systemic lupus erythematosus (SLE) NA NA
16 Rheumatoid arthritis NA NA
17 History of cancer chemotherapy NA NA
18 Vitamin deficiencies N NA
19 History of radiation therapy NA p = 0.638
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variant in the Duffy Antigen receptor for chemokines gene
[15]. Fewer studies have reported the incidence of this
condition in Middle Eastern population such as black Bed-
ouin Arabs (Shoenfeld et al., 1998). Chronic benign neu-
tropenia has not been associated with any increased risk of
infection and has also been described in other populations
around the world including Africans, African Americans
and Afro-Caribbean’s [10]. The findings from our studies
are similar to other earlier reports when the benign condi-
tion was matched with known potential causes for
observed low neutrophil counts.
Previous studies have reported that CBN in an Arab
tribe is inherited as an autosomal dominant trait with
an ANC < 2 x 109/L as a case of neutropenia (Shoenfeld
et al., 2010). One of the reasons for a high incidence in
Arab population could be due to founder gene effects as
well as the result of high percentages of consanguineous
marriages among the population. The geographical
proximity of Saudi Arabia with the North African coun-
tries could also be associated with the migration of
those people to the peninsula thus increasing the neu-
tropenia cases in the country.
Previous reports have shown the occurrence or degree of
disease severity in categories associated with those of CBN
in the Arab population [4,15]. The current study shows
that the prevalence of CBN is as high as 20% in subjects
with a mean of 1.48 (range 0.99–1.95) (×109cells/L), with-
out any significant differences between the sexes. Ethnicity
is reported to contribute to the neutrophils count and
hence our studies showed significant differences between
Saudi and non-Saudi population. We found concordant
decrease in the cell counts for neutrophils and monocytes
that indicate a common mechanism may be involved in
the regulation of the common progenitor from which these
cells arise, leading to CBN in the general population.
Common causes of neutropenia were excluded in this
study. Our findings support previous reports on neutrope-
nia in the Arab peninsula. In Saudi Arabia, the incidence
of neutropenia is reported mostly on people of Sudanese
origin. We observed that 20% of the random samples
selected had CBN. This supports the previous reports of
the exceptionally higher prevalence of CBN in this part of
the world.
Few studies have looked into the cause of congenital
neutropenia at the genomic level. Recent report by Xia
et al., (2009) [16] showed prevalence of mutations in
ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in
patients with severe congenital neutropenia. Among the
different mutation studied for neutropenia, mutations
associated with ELANE gene were found to be more
common [16]. Mutations in B-lymphocyte antigen
(CD19) associated with the WASP gene is one potential
genetic cause for neutropenia [17,18]. Plasma chemokine
levels, particularly CXCL8 and CCL2, were previously
reported to be higher in patients who were homozygous
Table 2 Study subjects, mean differential values and
prevalence of CBCs associated with chronic benign
neutropenia in the Kingdom of Saudi Arabia. A p value









(× 109/L) Mean (Range) Association with
neutrophil count
WBCs (× 109/L) 7.910(2.59-13.90) p = <0.05
Neutrophils (× 109/L) 3.350(0.99-8.88) p = <0.05
Lymphocytes (× 109/L) 3.240(0.77-5.96) p = <0.05
Monocytes (× 109/L) 0.809(0.001-2.19) p = <0.05
Eosinophiles (× 109/L) 0.024(0.008-1.49) p = <0.05
Basophils (× 109/L) 0.262(0.00-0.957) p = 0.167
CD3 % 70.68(56.29-94.03) p = 0.070
CD3 + CD8 % 28.93 (14.45-52.10> p = 0.062
CD3 + CD4 % 37.96(27.23-50 08) p = 0.590
CD16 +
CD56
% 13.64(0.14-31.74) p = 0.857
CD 19 % 13.97(0.07-26.90) p = < 0.05
Table 3 Correlation analysis describing the association
between neutrophils and different blood cell components
Number Cell types Correlation p- value
1 WBC r = 0.802** 0.000
2 Lymphocytes r = 0.301** 0.002
3 Monocytes r = 0.297** 0.003
4 Eosnophils r = 0.221* 0.027
5 Basophils r = 0.143 0.155
Table 4 Correlation analysis describing the association
between peripheral blood lymphocyte counts and
neutrophils. Numbers indicated in bold indicates




Correlation p = value
1 CD3 r = -0.279* 0.013
2 CD3+CD8 r = -0.229* 0.042
3 CD3+CD4 r = -0.110 0.337
4 CD16+CD56 r = 0.000 0.997
5 CD 19 r = 0.395** 0.000
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for the null allele when compared to patients who were
heterozygous following lipopolysaccharide stimulation of
their whole blood in vitro [19]. The evidence pointed at
a locus on chromosome 1q22 which could be responsi-
ble for this condition. Later it was found that this poly-
morphism mapped in this population is within the
Duffy antigen receptor chemokine (DARC) gene. This
gene encodes the Duffy antigen, a chemokine receptor
found on red blood cells [20].
Potential cause for the reduction of neutrophils could
be attributed to genetic factors especially genes asso-
ciated with the multipotent haematopoietic stem cell
pathway (Fig. 1). Multipotent haematopoietic stem cell
pathway is associated with the production of different
blood cell lineages including the lymphocyte subsets.
Genes associated with the neutrophils include SCF (KIT
ligand) growth factor, TPO (cytokine), G-CSF (growth
factor), IL-3 (interleukin), IL-5 (interleukin) (Table 5).
Aberrant mutations in these genes could result in the
inhibition of synthesis of neutrophils leading to a lower
neutrophil as well as other cell counts. It has been
found that TPO gene enhances neutrophil production
by bone marrow hematopoietic progenitors with the aid
of stem cell factor in congenital neutropenia [21].
Granulocyte colony-stimulating factor (G-CSF) plays a
key role in the hematopoietic stem cell pathway. Severe
congenital neutropenia was to found to be associated
with abnormal growth and differentiation of myeloid
progenitors to granulocyte colony-stimulating factor (G-
CSF). However they showed normal response to G-CSF
plus stem cell factor [22]. Similarly Interleukins (IL-3,
IL-4 and IL-5) play a key role in differentiation and pro-
liferation of hematopoietic cells [23]. Identification
mutations in genes across affected families in endemic
countries could lead to the identification of the cause
for the CBN in Middle East Countries.
Conclusions
Our studies show the mean neutrophil count in Saudi
populations affected with CBN is even lower than those
reported in the general Arab population. The concurrent
decrease in other peripheral blood mononuclear cell
counts is reported for the first time and this could be
Figure 1 Multipotent haematopoietic stem cell pathway associated with
the production of different blood cell lineages. The highlighted gene in
colour is associated with neutrophil production (SCF, TPO, G-CSF, IL-3, IL-
5). These genes need to be investigated further to screen for any
mutations that could result in an aberrant gene which could inhibit the
synthesis of neutrophils leading to a lower neutrophil count. EPO
(erythropoietin - cytokine), G-CSF (colony stimulating factor 3
(granulocyte) - cytokine), GM-CSF (colony stimulating factor 2
(granulocyte-macrophage) – cytokine), IL-15 (interleukin 15 – cytokine),
IL-2 interleukin 2 – (cytokine), IL-3 interleukin 3 – (cytokine), IL-4
(interleukin 4 – (cytokine), IL-5 (IL-5 interleukin 5 – (cytokine), IL-7
(interleukin 7 – (cytokine), M-CSF colony stimulating factor 1
(macrophage) - cytokine, SCF (KIT ligand) – growth factor, TPO
(thrombopoietin) – cytokine.
Table 5 Genes associated with haematopoiesis and that
could play a role in neutrophil count in chronic benign
neutropenia
Number Entrez Gene Name Symbol Family
1 Erytliropoietin EPO cytokine
2 Colony slimulaling factor 3
(granulocyte)
G-CSF cytokine
3 Colony slinuilaling factor 2
(granulocyte-macrophage)
GM-CSF cytokine
4 Interleukin 15 IL-15 c\1okine
5 Interleukin 2 IL-2 cytokine
6 Interleukin 3 (colony-stimulating factor,
multiple)
IL-3 other
7 Interleukin 4 IL-4 cytokine
8 Interleukin 5 (colony-stimulating factor,
eosinophil)
IL-5 cytokine
v Interleukin 7 II.-7 cytokine
10 Colony stimulating factor 1
(macrophage)
M-CSF cytokine
11 KIT ligand SCF growth
factor
12 Thrombopoietin TPO cytokine
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associated with a latent stage of even more severe condi-
tions associated with the CBN. Though these patients
do not present with any visible disease conditions, a
long-term plan should be put in place to monitor the
health conditions of these individuals. In the future, it is
recommended that a more extensive screening should
take place in the general population to dissect the
genetic basis of CBN in the Saudi Arabia population
and to determine if this is similar to other populations
that also have an increase in CBN.
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